Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates with worsening disease progression due to its implications in metastases and re- sistance to therapeutic interventions. Although EMT is known to occur in several types of solid tumors, the information concerning tumors arising from the epithelia of the bile tract is still limited. In order to approach the problem of EMT in cholangiocarcinoma, we decided to investigate the changes in protein expression occurring in two cell lines under conditions leading to growth as adherent monolayers or to formation of multicellular tumor spheroids (MCTS), which are considered culture models that better mimic the growth characteristics of in-vivo ...
Xing Yao,1,* Xiang Wang,1,* Zishu Wang,2,* Licheng Dai,1 Guolei Zhang,1 Qiang Yan,1 Weimin Zhou11Huz...
SummaryClinical complexity, anatomic diversity and molecular heterogeneity of cholangiocarcinoma (CC...
Cholangiocarcinoma (CCA) is a rare, aggressive disease with poor overall survival. In advanced cases...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Cholangiocarcinoma (CCA) is a deadly tumor without an effective therapy. Unique metabolic and bioene...
International audienceCholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to i...
In addition to its well-established role in embryo development, epithelial-to-mesenchymal transition...
The epithelial to mesenchymal transition (EMT) is a cellular program associated with the organ morph...
<div><p>Background</p><p>The aim of this study is to investigate the expression profile of multiple ...
Background: Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular aspects of...
International audienceBackground & Aims: Epithelial-mesenchymal transition (EMT) is a cellular proce...
Abstract Background: Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular a...
Xing Yao,1,* Xiang Wang,1,* Zishu Wang,2,* Licheng Dai,1 Guolei Zhang,1 Qiang Yan,1 Weimin Zhou11Huz...
SummaryClinical complexity, anatomic diversity and molecular heterogeneity of cholangiocarcinoma (CC...
Cholangiocarcinoma (CCA) is a rare, aggressive disease with poor overall survival. In advanced cases...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Epithelial-to-Mesenchymal Transition (EMT) is relevant in malignant growth and frequently correlates...
Cholangiocarcinoma (CCA) is a deadly tumor without an effective therapy. Unique metabolic and bioene...
International audienceCholangiocarcinoma (CCA) is an aggressive tumor with a poor prognosis due to i...
In addition to its well-established role in embryo development, epithelial-to-mesenchymal transition...
The epithelial to mesenchymal transition (EMT) is a cellular program associated with the organ morph...
<div><p>Background</p><p>The aim of this study is to investigate the expression profile of multiple ...
Background: Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular aspects of...
International audienceBackground & Aims: Epithelial-mesenchymal transition (EMT) is a cellular proce...
Abstract Background: Cholangiocarcinoma (CCA) is still a deadly tumour. Histological and molecular a...
Xing Yao,1,* Xiang Wang,1,* Zishu Wang,2,* Licheng Dai,1 Guolei Zhang,1 Qiang Yan,1 Weimin Zhou11Huz...
SummaryClinical complexity, anatomic diversity and molecular heterogeneity of cholangiocarcinoma (CC...
Cholangiocarcinoma (CCA) is a rare, aggressive disease with poor overall survival. In advanced cases...